Are We Prepared To Manage Anticoagulated ICH Patients or Should We Direct Them Elsewhere?

June 28, 2022
How and where to treat ICH patients- politics, reversal agents, and science all in one podcast!
1 Comments

AI in Imaging - We All Know It’s Coming. Are We Ready for the Machines in Stroke?

June 21, 2022
AI is coming but are we ready for it in stroke imaging?
0 Comments

Telemedicine and Stroke: What Have We Done?

June 14, 2022
Is telemedicine the savior for stroke care or the start part of the downfall of acute medicine?
0 Comments

Stroke Center Designations Are Big Business. Are They More Than That for Patient Care?

June 7, 2022
Stroke center designations are the currency of the realm; but does it matter to patients?
0 Comments

Telemedicine and Acute Stroke Research: What Is the State of the Union?

May 24, 2022

Telemedicine is the future of stroke - is it the future of stroke research?

0 Comments
RSS
245678910Last
Categories
More Entries

Jun 28

Are We Prepared To Manage Anticoagulated ICH Patients or Should We Direct Them Elsewhere?

Haemin Go posted on 6/28/2022


Moderator: Jordan Bonomo, MD, FCCM, FNCS
Other Participants: Chris Droege, PharmD, BCCCP, FCCM, FASHP and Christopher T. Richards, MD, MS, FAEMS, FACEP

Join this podcast to learn from EMS trained EM physician Dr. Richards and Critical Care Pharmacists Dr. Chris Droege as they tackle the sticky topic of how to reverse agents in ICH patients and whether or not to transfer these patients if specific reversal agents aren't available at first point of contact.  Factor neutralization, reversal, transfer protocols are all fair game in this fast moving podcast roundtable that touches on protocols, logistics and trial outcomes.


1 Comments

1 comments on article "Are We Prepared To Manage Anticoagulated ICH Patients or Should We Direct Them Elsewhere?"

Avatar image

Alain Leif Santiago,DLA

as stated

Please login or register to post comments.